Canada vs South-East Asia (WHO region): Diabetes treatment coverage, crude
Canada
68.21
in 2022
South-East Asia (WHO region)
28.37
in 2022
Canada rank
11th
South-East Asia (WHO region) rank
9th
Diabetes treatment coverage, crude over time
- Canada
- South-East Asia (WHO region)
How they compare
Canada currently reports 68.21 against 28.37 in South-East Asia (WHO region), a difference of 39.84.
That makes Canada's figure about 2.4 times South-East Asia (WHO region)'s.
Across all 33 years both countries report, Canada has been ahead every year.
Canada ranks 11th and South-East Asia (WHO region) ranks 9th of 198 countries.
Canada has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Canada | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 41.01 | 23.2 | 17.81 | Canada |
| 2000s | 49.65 | 24.29 | 25.36 | Canada |
| 2010s | 60.57 | 26.87 | 33.7 | Canada |
| 2020s | 67.3 | 28.21 | 39.09 | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher diabetes treatment coverage, crude, Canada or South-East Asia (WHO region)?
- Canada, at 68.21 against 28.37 in South-East Asia (WHO region) as of 2022.
- What is the difference in diabetes treatment coverage, crude between Canada and South-East Asia (WHO region)?
- 39.84, with Canada ahead.
- How many years of comparable data are there for Canada and South-East Asia (WHO region)?
- 33 years are reported by both, from 1990 to 2022.
- How do Canada and South-East Asia (WHO region) rank globally for diabetes treatment coverage, crude?
- Canada ranks 11th and South-East Asia (WHO region) ranks 9th of 198 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Diabetes treatment coverage, crude. Statizoid refreshes it automatically from the source and publishes the full history for both places.